Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study

Kannan Sridharan, Mattia Alberto Di Civita, Gowri Sivaramakrishnan, Luca Zacco, Wataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, Jindrich Kopecky, Tarek Taha, Gian Paolo Spinelli, Tomas Buchler, Brigida Anna Maiorano, Andrea Malgeri, Linda Cerbone, Fabio Calabrò, Jawaher Ansari, Se Hoon Park, Aristotelis Bamias, Daniele Santini, Matteo Santoni

Open source

DOI: 10.1080/14737140.2026.2733827
Published: 2026-09-16
Container: Expert Review of Anticancer Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14737140.2026.2733827,
  title = {Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study},
  author = {Kannan Sridharan and Mattia Alberto Di Civita and Gowri Sivaramakrishnan and Luca Zacco and Wataru Fukuokaya and Takahiro Kimura and Takafumi Yanagisawa and Jindrich Kopecky and Tarek Taha and Gian Paolo Spinelli and Tomas Buchler and Brigida Anna Maiorano and Andrea Malgeri and Linda Cerbone and Fabio Calabrò and Jawaher Ansari and Se Hoon Park and Aristotelis Bamias and Daniele Santini and Matteo Santoni},
  year = {2026},
  journal = {Expert Review of Anticancer Therapy},
  doi = {10.1080/14737140.2026.2733827},
  url = {https://doi.org/10.1080/14737140.2026.2733827}
}

RIS

TY  - JOUR
TI  - Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study
AU  - Kannan Sridharan
AU  - Mattia Alberto Di Civita
AU  - Gowri Sivaramakrishnan
AU  - Luca Zacco
AU  - Wataru Fukuokaya
AU  - Takahiro Kimura
AU  - Takafumi Yanagisawa
AU  - Jindrich Kopecky
AU  - Tarek Taha
AU  - Gian Paolo Spinelli
AU  - Tomas Buchler
AU  - Brigida Anna Maiorano
AU  - Andrea Malgeri
AU  - Linda Cerbone
AU  - Fabio Calabrò
AU  - Jawaher Ansari
AU  - Se Hoon Park
AU  - Aristotelis Bamias
AU  - Daniele Santini
AU  - Matteo Santoni
PY  - 2026
JO  - Expert Review of Anticancer Therapy
DO  - 10.1080/14737140.2026.2733827
UR  - https://doi.org/10.1080/14737140.2026.2733827
ER  -

APA

Sridharan, K., Civita, M. A. D., Sivaramakrishnan, G., Zacco, L., Fukuokaya, W., Kimura, T., Yanagisawa, T., Kopecky, J., Taha, T., Spinelli, G. P., Buchler, T., Maiorano, B. A., Malgeri, A., Cerbone, L., Calabrò, F., Ansari, J., Park, S. H., Bamias, A., Santini, D., & Santoni, M. (2026). Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study. Expert Review of Anticancer Therapy. https://doi.org/10.1080/14737140.2026.2733827

Source records

crossref · retrieved 2026-09-25T22:26:08.947Z